Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2324]
News [5462]
Articles [134]
Editorials [4]
Conferences [158]
elearning [13]
Treating adenocarcinoma with bevacizumab
Prof Ken O’Byrne – St James’s Hospital, Dublin, Ireland
Treating adenocarcinoma with bevacizumab ( Prof Ken O’Byrne – St James’s Hospital, Dublin, Ireland )
15 May 2013
Update on the METABRIC consortium 2000 Breast Cancer Study
Prof Carlos Caldas - University of Cambridge, UK
Update on the METABRIC consortium 2000 Breast Cancer Study ( Prof Carlos Caldas - University of Cambridge, UK )
14 May 2013
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast...
Prof Charles Perou - University of North Carolina School of Medicine, USA
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer ( Prof Charles Perou - University of North Carolina School of Medicine, USA )
14 May 2013
Genetic alterations in postmenopausal women with hormone receptor-positive...
Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
14 May 2013
Implementation of individualised treatment and the WINTHER trial
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Implementation of individualised treatment and the WINTHER trial ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Importance of personalised medicine and the WIN Consortium
Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller
Importance of personalised medicine and the WIN Consortium ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )
30 Apr 2013
Goal of the 2013 WIN Symposium
Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller
Goal of the 2013 WIN Symposium ( Dr John Mendelsohn, Dr Richard Schilsky, Dr Richard Buller )
23 Apr 2013
Myc inhibition in pre-clinical mouse models
Dr Laura Soucek - Vall d'Hebron Institute of Oncology
Myc inhibition in pre-clinical mouse models ( Dr Laura Soucek - Vall d'Hebron Institute of Oncology )
22 Apr 2013
Next generation gene sequencing
Dr John Mendelsohn – MD Anderson Cancer Center, Houston, TX, USA
Next generation gene sequencing ( Dr John Mendelsohn – MD Anderson Cancer Center, Houston, TX, USA )
19 Apr 2013
Next generation PI3 kinase inhibition
Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US
Next generation PI3 kinase inhibition ( Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US )
19 Apr 2013
Targeting tumour suppressor genes
Dr Douglas Lowy - National Cancer Institute, Bethesda, USA
Targeting tumour suppressor genes ( Dr Douglas Lowy - National Cancer Institute, Bethesda, USA )
19 Apr 2013
Potential novel inhibitor to overcome drug resistance induced by RAF, MEK...
Dr Ahmed Samatar - Merck Research Laboratories, Boston, USA
Potential novel inhibitor to overcome drug resistance induced by RAF, MEK Inhibitors ( Dr Ahmed Samatar - Merck Research Laboratories, Boston, USA )
8 Apr 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation